Related Experiment Video

Updated: May 30, 2026

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
06:29

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques

Published on: June 11, 2019

Stress cardiomyopathy complicated by left ventricular thrombi and cerebral infarctions in a patient with essential

Seung Hwan Hwang1, Kye Hun Kim, Hyun Ju Yoon

  • 1Department of Cardiovascular Medicine, Chonnam National University Hospital, The Research Institute of Medical Sciences, Chonnam National University, Gwangju, Korea.

Journal of Cardiovascular Ultrasound
|August 24, 2011
PubMed

Insights

Stress induced cardiomyopathy (SCMP) can have rare but serious complications like blood clots. This case highlights successful treatment of left ventricular thrombosis and cerebral infarctions in a patient with essential thrombocythemia.

Area of Science:

  • Cardiology
  • Neurology
  • Hematology

Background:

  • Stress induced cardiomyopathy (SCMP) typically has a good prognosis.
  • However, severe complications including cardiac rupture and left ventricular (LV) thrombosis can occur.
  • Essential thrombocythemia is a myeloproliferative disorder associated with increased thrombotic risk.

Observation:

  • A rare case of SCMP complicated by LV thrombosis and multiple cerebral infarctions is presented.
  • The patient had a history of essential thrombocythemia.
  • The patient presented with neurological symptoms and cardiac dysfunction.

Findings:

  • Intravenous heparin anticoagulation was initiated for LV thrombosis and cerebral infarctions.
  • Comprehensive management for heart failure and neurological deficits was administered.
  • The patient showed improvement in neurological symptoms and LV apical wall motion abnormalities.
  • Follow-up echocardiography confirmed the resolution of the LV thrombus.

Implications:

  • This case underscores the importance of considering thrombotic complications in SCMP, especially in patients with underlying prothrombotic conditions.
  • Prompt anticoagulation and multidisciplinary management can lead to favorable outcomes.
  • Further research may elucidate the specific mechanisms linking SCMP, essential thrombocythemia, and thromboembolic events.

Keywords:
CardiomyopathyThrombocythemiaThromboembolism

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...